HEALTHX305.00

Health X Platform Limited

· Pharma & Health
₹ CrorePeersSURAKSHAKRSNAANEPHROPLUS3BBLACKBIOMcap ₹970 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation9.15.86.6
+ Finance Costs1.00.20.8
+ Interest Income-22.8-15.1-16.8
+ Dividend Income-0.2-0.3-1.8
+ Fair Value (Gains) / Losses-32.7-21.9-19.3
+ Other Non-cash Items5.0-0.34.0
+ Other — Cash Effects are Investing / Financing-19.9-31.7-29.8
+ Other Reconciling Items0.0190.60.0
Changes in Working Capital
+ Inventories65.05.5-34.4
+ Trade Receivables — Current-11.120.31.8
+ Other Financial Assets — Current-2.00.03.9
+ Other Financial Assets — Non-current-0.31.90.0
+ Other Current Assets8.30.00.0
+ Other Non-current Assets0.00.0-16.8
+ Other Bank Balances0.026.90.0
+ Trade Payables — Current-14.10.028.1
+ Other Financial Liabilities — Current2.12.82.6
+ Other Current Liabilities1.6-4.00.0
+ Other Non-current Liabilities0.00.04.2
+ Provisions — Current-0.5-0.8-0.4
+ Provisions — Non-current0.00.00.0
Cash from Operating Activities
Profit Before Tax (per I/S)55.7-192.9-2.4-30.6
+ Total Adjustments (incl. Working Capital)-11.4180.0-67.1
Cash from Operations (pre-tax)44.3-12.9-69.5
+ Income Taxes Paid6.14.54.3
Cash from Operating Activities38.2-17.3-73.8
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)14.210.414.9
+ Disp of Fixed Assets0.60.30.1
+ Acq of Other Long-term Assets897.60.00.0
+ Disp of Other Long-term Assets697.20.00.0
+ Purchase of Investments (Equity / Debt)0.0708.0703.6
+ Sale of Investments (Equity / Debt)0.0662.5800.5
+ Disp of Subsidiaries / Businesses (net)0.00.00.0
+ Dividends Received — Investing0.20.31.8
+ Interest Received — Investing21.711.811.3
+ Other Inflows / (Outflows) — Investing158.142.476.0
Cash from Investing Activities-33.9-1.1171.2
Cash from Financing Activities
+ Payments — Change in Ownership of Subsidiaries0.00.0100.0
+ Proceeds from Borrowings0.00.022.1
+ Payment of Lease Liabilities2.30.41.1
+ Interest Paid0.10.10.6
Cash from Financing Activities-2.4-0.4-79.6
Net Changes in Cash (pre-FX)1.9-18.917.8
Net Changes in Cash1.9-18.917.8
Closing Cash33.6
Reference Items
EBITDA5.4-56.0-52.1-66.5
EBITDA Margin %0.39-5.04-3.95-4.53
Free Cash Flow (CFO − Capex)23.9-27.7-88.8-88.8
Free Cash Flow per Basic Share7.52-8.70-27.90-27.90
Cash Flow to Net Income6.520.1351.01
Cash Paid for Taxes6.14.54.3
Cash Paid for Interest0.10.10.6
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.